Cell Therapies have completely transformed healthcare by harnessing the power of live cells to both treat and prevent diseases. During a recent interview, Behzad Mahdavi, Executive Chairman of the Board of Directors at OpenCell Technologies, Inc., discussed with Muhammad Younis the fundamental principles and essential methodologies underpinning this groundbreaking field.
11 Feb, 2024: The UK’s Department of Science and Technology has unveiled a £100 million funding initiative for BioTech initiatives nationwide, aimed at pandemic preparedness, agricultural innovation, and protection against floods. The funds will be disbursed among six new ‘Engineering Biology Mission Hubs’ and 22 ‘Mission Award’ projects across
Blood cancers pose a significant threat to humanity, claiming numerous lives relentlessly. In a recent interview, Lore Gruenbaum, VP of the Research Therapy Acceleration Program at The Leukemia & Lymphoma Society, talked with Muhammad Younis about the multifaceted response to this global crisis. Lore discussed advancements in treatment and envisioned
Throughout history, humanity's quest for healing has undergone an extraordinary evolution. From ancient remedies sourced from nature to chemically synthesized pharmaceuticals, each phase brought progress but also suffered from limitations. Traditional medicines often provided relief without addressing the core of complex diseases, leaving patients with just symptomatic relief
15 Jan, 2024: Scientists have unveiled a novel CRISPR-Cas toolkit called "pAblo·pCasso" to transform bacterial genome manipulation by offering unmatched precision and flexibility in genetic alteration. Created by scientists at The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain), this innovative technology broadens the scope of genomic